Quinones as Neuroprotective Agents [PDF]
Antioxidants, 2023 Quinones can in principle be viewed as a double-edged sword in the treatment of neurodegenerative diseases, since they are often cytoprotective but can also be cytotoxic due to covalent and redox modification of biomolecules.
Ángel Cores +4 more
doaj +5 more sources
Carbon nanotubes as neuroprotective agents [PDF]
Exploration of Neuroprotective TherapyCarbon nanotubes, an emerging class of carbon nanomaterials, possess tremendous potential for application in biotechnology and biomedicine particularly in neurological disorders.
Daisy L. Wilson +2 more
doaj +4 more sources
Fiscalin Derivatives as Potential Neuroprotective Agents [PDF]
Pharmaceutics, 2022 Neurodegenerative diseases (ND) share common molecular/cellular mechanisms that contribute to their progression and pathogenesis. In this sense, we are here proposing new neuroprotection strategies by using marine-derived compounds as fiscalins.
Sandra Barreiro +6 more
doaj +4 more sources
Neuroprotective Agents with Therapeutic Potential for COVID-19 [PDF]
Biomolecules, 2023 COVID-19 patients can exhibit a wide range of clinical manifestations affecting various organs and systems. Neurological symptoms have been reported in COVID-19 patients, both during the acute phase of the illness and in cases of long-term COVID ...
César A. Zaa +4 more
doaj +2 more sources
Neuroprotective Agents in the Intensive Care Unit - Neuroprotective Agents in ICU -
Journal of Pharmacopuncture, 2018 Neuroprotection or prevention of neuronal loss is a complicated molecular process that is mediated by various cellular pathways. Use of different pharmacological agents as neuroprotectants has been reported especially in the last decades.
Yunes Panahi +5 more
doaj +3 more sources
Nutraceutical Antioxidants as Novel Neuroprotective Agents [PDF]
Molecules, 2010 A variety of antioxidant compounds derived from natural products (nutraceuticals) have demonstrated neuroprotective activity in either in vitro or in vivo models of neuronal cell death or neurodegeneration, respectively.
Daniel A. Linseman +2 more
doaj +3 more sources
Mining and evaluation of security alert signals of neuroprotective agents based on the Jinan adverse event reporting system database: a retrospective study [PDF]
Frontiers in PharmacologyBackgroundPharmacologic agents with proposed neuroprotective properties are increasingly investigated; however, limited regulation and heterogeneous evidence raise concerns about their safety profiles. To establish a foundation for its safe clinical use,
Yu-yao Guan +4 more
doaj +2 more sources
Current neuroprotective agents in stroke [PDF]
Turk J Phys Med RehabilWhat is expected from neuroprotection is to inhibit neuronal death and halt or decelerate the neuronal loss to lower the mortality rates, decrease disability, and improve the quality of life following an acute ischemic stroke. Several agents were described as neuroprotective up to date; however, there is still debate which to use in the ...
Yanık T, Yanık B.
europepmc +3 more sources
Comparative efficacy of neuroprotective agents for improving neurological function and prognosis in acute ischemic stroke: a network meta-analysis [PDF]
Frontiers in NeuroscienceBackgroundIschemic stroke is the second leading cause of death and the third leading cause of combined disability and mortality globally. While reperfusion therapies play a critical role in the management of acute ischemic stroke (AIS), their ...
Yuchen Wang +6 more
doaj +2 more sources
2024 international conference on neuroprotective agents conference proceedings [PDF]
Experimental Biology and MedicineWilliam Slikker +3 more
doaj +2 more sources